In addition to the fact that TP53 was the only significant co-alteration seen in our patient with lung cancer, comparison of WES with HRD-associated genomic signatures from 814 other tumors of diverse histologies revealed strong concordance with the pattern exhibited by classic BRCA-associated malignancies. Here, TP53 is linked to lung carcinoma.